Track cost pressure
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.
Active filters
| Presentation | Product | Chemical substance | Chapter | Items dispensed |
|---|---|---|---|---|
|
Flupentixol 100mg/1ml solution for injection ampoules
0402020G0AAABAB
|
Flupentixol decanoate | Flupentixol decanoate | Central Nervous System | 2,915 |
|
Depixol Conc 100mg/1ml solution for injection ampoules
0402020G0BBADAB
|
Depixol (Parenteral) | Flupentixol decanoate | Central Nervous System | 1,863 |
|
Depixol 40mg/2ml solution for injection ampoules
0402020G0BBABAC
|
Depixol (Parenteral) | Flupentixol decanoate | Central Nervous System | 1,624 |
|
Flupentixol 40mg/2ml solution for injection ampoules
0402020G0AAACAC
|
Flupentixol decanoate | Flupentixol decanoate | Central Nervous System | 1,316 |
|
Flupentixol 200mg/1ml solution for injection ampoules
0402020G0AAAIAI
|
Flupentixol decanoate | Flupentixol decanoate | Central Nervous System | 1,294 |
|
Depixol 20mg/1ml solution for injection ampoules
0402020G0BBAAAA
|
Depixol (Parenteral) | Flupentixol decanoate | Central Nervous System | 1,206 |
|
Flupentixol 20mg/1ml solution for injection ampoules
0402020G0AAAAAA
|
Flupentixol decanoate | Flupentixol decanoate | Central Nervous System | 1,126 |
|
Depixol Low Volume 200mg/1ml solution for injection ampoules
0402020G0BBAGAI
|
Depixol (Parenteral) | Flupentixol decanoate | Central Nervous System | 480 |
|
Flupentixol 50mg/0.5ml solution for injection ampoules
0402020G0AAAHAH
|
Flupentixol decanoate | Flupentixol decanoate | Central Nervous System | 399 |
|
Psytixol 50mg/0.5ml solution for injection ampoules
0402020G0BCACAH
|
Psytixol | Flupentixol decanoate | Central Nervous System | 5 |
|
Psytixol 100mg/1ml solution for injection ampoules
0402020G0BCADAB
|
Psytixol | Flupentixol decanoate | Central Nervous System | 4 |
|
Depixol Conc 50mg/0.5ml solution for injection ampoules
0402020G0BBAFAH
|
Depixol (Parenteral) | Flupentixol decanoate | Central Nervous System | 1 |
|
Psytixol 200mg/1ml solution for injection ampoules
0402020G0BCAEAI
|
Psytixol | Flupentixol decanoate | Central Nervous System | 1 |
|
Psytixol 20mg/1ml solution for injection ampoules
0402020G0BCAAAA
|
Psytixol | Flupentixol decanoate | Central Nervous System | No data available |
|
Psytixol 40mg/2ml solution for injection ampoules
0402020G0BCABAC
|
Psytixol | Flupentixol decanoate | Central Nervous System | No data available |
Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.